Rare Heart Disease Strikes Sisters: A Battle for Life

Megan Kaverman faced years of unexplained fatigue and shortness of breath before a 2016 emergency room visit revealed early stages of heart failure. Intensive diagnosis identified heritable pulmonary arterial hypertension, a rare genetic disease causing lung artery narrowing and high blood pressure. This condition, accounting for less than 4% of pulmonary arterial hypertension cases, often leads to heart failure before diagnosis.

Kaverman's experience prompted her to urge her sister, Katie Gusching, to seek medical attention when she developed similar symptoms. Gusching was also diagnosed with the same rare condition, with Kaverman crediting her sister's advocacy for saving her life. Both sisters are receiving treatment at the Cleveland Clinic, where doctors are researching new therapies.

Dr. Kristen Highland, a pulmonologist at the clinic, noted significant advancements in treatment options, bringing much more hope to patients. Kaverman and Gusching are now active advocates, sharing their stories to raise awareness and encourage others with unresolved cardiac symptoms to inquire about pulmonary hypertension. Both sisters are currently managing their condition effectively, enabling them to return to activities they once thought impossible and strengthening their bond.